Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FYN | P06241 | 3/20 | 0.41 |
| ▸ | CXCR6 | O00574 | 11/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | JAK1 | P23458 | 1/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.37 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
| ▸ | LDHA | P00338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15220286 | 1.00 | FYN (0.41) | FYNCXCR6PDE4CERN1TLR9 | |
| SCHEMBL15220271 | 1.00 | FYN (0.41) | FYNCXCR6PDE4CERN1TLR9 | |
| SCHEMBL16438193 | 1.00 | FYN (0.41) | FYNCXCR6PDE4CERN1TLR9 | |
| SCHEMBL15210490 | 0.91 | FYN (0.40) | FYNCXCR6PDE4CJAK2JAK1 | |
| SCHEMBL10267295 | 0.86 | SYK (0.42) | FYNCXCR6PDE4CERN1JAK2 | |
| SCHEMBL723539 | 0.86 | MAPK1 (0.48) | FYNCXCR6PDE4CERN1 | |
| SCHEMBL10269029 | 0.86 | SYK (0.42) | FYNCXCR6PDE4CERN1JAK2 | |
| SCHEMBL15210413 | 0.86 | FYN (0.38) | FYNCXCR6PDE4CJAK2JAK1 | |
| SCHEMBL724106 | 0.85 | PDE4C (0.44) | FYNPDE4CJAK2JAK1TYK2 | |
| SCHEMBL721276 | 0.84 | USP30 (0.40) | FYNCXCR6ERN1JAK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2817313-B1 | FUROPYRIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2016-09-07 | — | — | EP | claimed |
| US-20150038527-A1 | FUROPYRIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2015-02-05 | — | — | US | claimed |
| EP-2817313-A1 | FUROPYRIDINE DERIVATIVES | Merck Patent GmbH (DE) | 2014-12-31 | — | — | EP | claimed |
| CN-104114558-A | Furopyridine derivatives | MERCK PATENT GMBH | 2014-10-22 | — | — | CN | claimed |
| WO-2013124025-A1 | FUROPYRIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2013-08-29 | — | — | WO | claimed |
| EP-2817313-B1 | FUROPYRIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2016-09-07 | — | — | EP | disclosed |
| US-20150038527-A1 | FUROPYRIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2015-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038527-A1 | FUROPYRIDINE DERIVATIVES | SYK, LYN, BTK | FYN 31/4885CXCR6 2262/4885PDE4C 3343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.